Portfolio check: The biggest SA Quant upgrades over the past week
Source: SeekingAlpha
2026-05-27 09:52:35 ET
Related to this article
- Vertex Pharmaceuticals Q1 Earnings Review: Pharma May Need Bolder M&A Strategy
- Keysight Technologies: Further Stock Price Gains Unsupported By Fundamentals
- Fastenal Company: Tariff Concerns On Top Of An Expensive Valuation
Read the full article on Seeking Alpha
For further details see:
Portfolio check: The biggest SA Quant upgrades over the past week
Vertex Pharmaceuticals Incorporated
NASDAQ: VRTX
VRTX Trading
2.32% G/L:
$452.60 Last:
534,454 Volume:
$445.605 Open:
VRTX Latest News
June 05, 2026 12:00:00 pm
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference
June 03, 2026 04:00:00 pm
Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10
VRTX Stock Data
$118,425,801,558
253,211,393
0.21%
875
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
